Nonischemic dilated cardiomyopathy (DCM) often has a genetic pathogenesis. Because of
the large number of genes and alleles attributed to DCM, comprehensive genetic testing …

Advances in human genome sequencing have re-invigorated genetics studies of dilated
cardiomyopathy (DCM), facilitating genetic testing and clinical applications. With a range of …

Background: Genetic analysis is a first-tier test in dilated cardiomyopathy (DCM). Electrical
phenotypes are common in genetic DCM, but their exact contribution to the clinical course …

Remarkable progress has been made in understanding the genetic basis of dilated
cardiomyopathy (DCM). Rare variants in> 30 genes, some also involved in other …

Dilated cardiomyopathy (DCM) is a myocardial disorder defined by ventricular chamber
enlargement and systolic dysfunction that can result in progressive heart failure …

Dilated cardiomyopathy (DCM), usually diagnosed as idiopathic dilated cardiomyopathy
(IDC), has been shown to have a familial basis in 20–35% of cases. Genetic studies in …

Our insight into the diverse and complex nature of dilated cardiomyopathy (DCM) genetic
architecture continues to evolve rapidly. The foundations of DCM genetics rest on marked …

Background The clinical relevance of genetic variants in nonischemic dilated
cardiomyopathy (DCM) is unsettled. Objectives The study sought to assess the prognostic …

Dilated Cardiomyopathy Overview - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter …

Background: Genotype-phenotype correlations in dilated cardiomyopathy (DCM) and, in
particular, the effects of gene variants on clinical outcomes remain poorly understood …